The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Bacillus Calmette-guerin Immunotherapy of Superficial Bladder Cancer
Abstract
Thirty-seven patients were enrolled in a randomized prospective study to compare standard surgical therapy for superficial bladder cancer to standard therapy plus bacillus Calmette-Guerin (BCG). Side effects of BCG have been tolerated well and include dysuria in 95 per cent of the patients, urinary frequency in 83 per cent, hematuria in 39 per cent, fever in 22 per cent and nausea in 22 per cent. Of 19 control patients 8 (42 per cent) had recurrent tumors in the followup period, compared to 3 of 18 patients (17 per cent) treated with BCG. One patient treated wih BCG had 2 recurrences, yielding a recurrence rate of 22 per cent in the group receiving BCG compared to 42 per cent in controls. When the incidence of recurrent tumors in matched intervals before and after entry into the protocol is compared, no change in the rate of tumor recurrence (p equals 0.726 chi-square) occurred in controls, whereas tumor recurrences were reduced significantly in the group treated with BCG (p equals 0.010 chi-square). The reduction in tumor recurrence in patients treated with BCG compared to controls is statistically significant (p equals 0.029 chi-square). Of 4 patients who presented with new bladder tumors remain free of tumor after BCG therapy, while 2 of 5 comparable control patients developed recurrent tumors. Intravesical and percutaneous BCG immunotherapy appears to decrease the rate of tumor recurrence in patients followed for 1 year.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors
Morales, A., Eidinger, D., & Bruce, A. W. (1976) · Journal of Urology · doi:10.1016/s0022-5347(17)58737-6 · Cited by 1,791
Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors
Morales, A., Eidinger, D., & Bruce, A. W. (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.101 · Cited by 1,533
Intracavitary bacillus Calmette-Grerin in the treatement of superficial bladder tumors
Morales, A. (1976) · The Journal of Urology · Cited by 978
Bast, R. C., Zbar, B., Borsos, T., & Rapp, H. J. (1974) · New England Journal of Medicine · doi:10.1056/nejm197406202902506 · Cited by 305
Bast, R. C., Zbar, B., Borsos, T., & Rapp, H. J. (1974) · New England Journal of Medicine · doi:10.1056/nejm197406272902605 · Cited by 235
De novo malignant tumors in organ transplant recipients.
Penn, I., Halgrimson, C. G., & Starzl, T. E. (1971) · PubMed · Cited by 158
Nonspecific Immunotherapy with BCG Vaccine in Bladder Tumors
Martinez-Piñeiro, J. A., & Muntañola, P. (1977) · European Urology · doi:10.1159/000472047 · Cited by 57
Cited by
A timeline of tumour-associated macrophage biology
Cassetta, L., & Pollard, J. W. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00547-1 · Cited by 581
BCG immunotherapy of bladder cancer: 20 years on
Alexandroff, A. B., Jackson, A. M., O'Donnell, M. A., & James, K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07422-4 · Cited by 471
Mechanisms of BCG immunotherapy and its outlook for bladder cancer
Pettenati, C., & Ingersoll, M. A. (2018) · Nature Reviews Urology · doi:10.1038/s41585-018-0055-4 · Cited by 457
History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story
Herr, H. W., & Morales, A. (2008) · Journal of Urology · doi:10.1016/j.juro.2007.08.122 · Cited by 353
Experience with Bacillus Calmette-Guerin in Patients with Superficial Bladder Carcinoma
Brosman, S. A. (1982) · Journal of Urology · doi:10.1016/s0022-5347(17)52736-6 · Cited by 314
Metadata
- Authors
- Lamm, D. L., Thor, D. E., Harris, S. C., Reyna, J. A., Stogdill, V. D., & Radwin, H. M.
- Venue
- Journal of Urology
- Published
- 1980-07
- Volume
- 124
- Issue
- 1
- Pages
- 38-42
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W229384513
- Cited by
- 333
- References
- 9
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bacillus Calmette-guerin Immunotherapy of Superficial Bladder Cancer. https://app.cochat.ai/papers/10.1016/s0022-5347(17)55282-9
- The paper
- Lamm, D. L., Thor, D. E., Harris, S. C., Reyna, J. A., Stogdill, V. D., & Radwin, H. M. (1980). Bacillus Calmette-guerin Immunotherapy of Superficial Bladder Cancer. Journal of Urology. https://doi.org/10.1016/s0022-5347(17)55282-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.